Press Release by Heart Rhythm 2017, July 11, 2017 Media Contact Shane Osborne Heart Rhythm Society media@hrsonline.org 202-464-3431 The 2017 Atrial Fibrillation (AFib) Screening and Education Initiative is designed to increase awareness of AFib among patients and caregivers, support the development of an AFib screening and education program, and collect […]
Other News
Spectranetics (SPNC) Announces Second Quarter Earnings Release Date
COLORADO SPRINGS, Colo., July 13, 2017 (GLOBE NEWSWIRE) — The Spectranetics Corporation (NASDAQ:SPNC) (“the Company”) today announced that it will release financial results for the second quarter ended June 30, 2017, after market close on August 3, 2017. Due to the pending transaction with Royal Philips, the Company will not hold an […]
LeMaitre Vascular, Inc. Will Announce Second Quarter 2017 Earnings Results On July 27, 2017
BURLINGTON, Mass., July 13, 2017 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2017 financial results on Thursday, July 27, 2017, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the […]
REVA Medical Cuts Jobs, Shakes Up C-Suite
SAN DIEGO, July 13, 2017 (GLOBE NEWSWIRE) — REVA Medical, Inc. (ASX:RVA), as part of its transition to commercial operations, today announced the hiring of a new chief financial officer, a vice president of European sales, and the appointment of a new director to its board. These changes signal the […]
Testing a soft artificial heart
Press release by ETH, By: Franziska Schmid ETH researchers from the Functional Materials Laboratory have developed a silicone heart that beats almost like a human heart. In collaboration with colleagues from the Product Development Group Zurich, they have tested how well it works. The artificial heart imitates a human heart as closely […]
iBeat, the Lifesaving Smartwatch, Extends Seed Round to $4.5 Million; Builds Out Executive Bench with Hires from Apple and Stanford
SAN FRANCISCO–(BUSINESS WIRE)–iBeat, a wearable technology company empowering people to live longer lives, today announced it has closed another $3 million in funding, bringing its total seed stage funding to $4.5 million. New investors include WTI, SV Tech Ventures, Lee Equity, and renowned entrepreneurs and angel investors Michael Rubin, Mark Burg, and Harald Ludwig. They join […]
Robbins Arroyo LLP: Avinger, Inc. (AVGR) Misled Shareholders According to a Class Action
SAN DIEGO & REDWOOD CITY, Calif.–(BUSINESS WIRE)–Shareholder rights law firm Robbins Arroyo LLP announces that a class action complaint was filed against Avinger, Inc. (NasdaqGM: AVGR) on behalf of all purchasers of Avinger securities pursuant to the company’s initial public offering on January 30, 2015 (the “Offering”), for alleged violations of the […]
Gore Announces First-in-Human Use of GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System for TEVAR
FLAGSTAFF, Ariz.–(BUSINESS WIRE)–W. L. Gore & Associates, Inc. (Gore) today announced the first patient implant of the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System after receiving CE Mark last month. The first implant was performed by Prof. Dr. med. Giovanni Torsello and Dr. med. Martin Austermann at […]
Clinical Trial to Evaluate Medtronic Cryoablation as First-Line Treatment for Patients With Symptomatic Paroxysmal Atrial Fibrillation
Press Release DUBLIN – July 11, 2017 – Medtronic plc (NYSE: MDT) today announced first enrollments in the STOP AF First clinical trial. The trial will evaluate the safety and effectiveness of performing pulmonary vein isolation (PVI) with the Arctic Front Advance(TM) Cryoballoon in patients with symptomatic paroxysmal atrial fibrillation (AF) prior […]
Medtronic Expands TAVR Access to More Patients With Symptomatic, Severe Aortic Stenosis Upon Intermediate Risk FDA Approval
Press Release DUBLIN – July 10, 2017 – Medtronic plc (NYSE: MDT) today announced the expanded U.S. Food and Drug Administration (FDA) approval of the self-expanding CoreValve(TM) Evolut(TM) transcatheter aortic valve replacement (TAVR) platform to include patients with symptomatic severe aortic stenosis who are at an intermediate risk for open-heart surgery. […]



